{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:24:14Z","timestamp":1770740654880,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010275","name":"Deutsche Gesellschaft f\u00fcr Muskelkranke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010571","name":"Bundesministerium f\u00fcr Bildung, Wissenschaft, Forschung und Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.neulet.2016.07.039","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T11:34:39Z","timestamp":1469187279000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Down-regulation of purinergic P2X7 receptor expression and intracellular calcium dysregulation in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"630","author":[{"given":"Jingyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tino","family":"Prell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Stubendorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Keiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Ringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Gunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vedrana","family":"Tadic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Goldhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Malci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto W.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Grosskreutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2016.07.039_bib0005","doi-asserted-by":"crossref","first-page":"e0117848","DOI":"10.1371\/journal.pone.0117848","article-title":"Genetic background effects on disease onset and lifespan of the mutant dynactin p150Glued mouse model of motor neuron disease","volume":"10","author":"Heiman-Patterson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2016.07.039_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ceca.2006.11.010","article-title":"Role of mitochondria in kainate-induced fast Ca2+ transients in cultured spinal motor neurons","volume":"42","author":"Grosskreutz","year":"2007","journal-title":"Cell Calcium."},{"key":"10.1016\/j.neulet.2016.07.039_bib0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0968-0004(00)01588-7","article-title":"Calcium, a signaling molecule in the endoplasmic reticulum?","volume":"25","author":"Corbett","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neulet.2016.07.039_bib0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ceca.2009.12.002","article-title":"Calcium dysregulation in amyotrophic lateral sclerosis","volume":"47","author":"Grosskreutz","year":"2010","journal-title":"Cell Calcium."},{"key":"10.1016\/j.neulet.2016.07.039_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2011.01.016","article-title":"Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: mechanistic relationship and differential sensitivity to intervention","volume":"42","author":"Tradewell","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2016.07.039_bib0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/exnr.1999.7190","article-title":"ALS-linked Cu\/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis","volume":"160","author":"Kruman","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0035","doi-asserted-by":"crossref","first-page":"e25545","DOI":"10.1371\/journal.pone.0025545","article-title":"Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells","volume":"6","author":"Nardo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2016.07.039_bib0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jneuroim.2004.10.009","article-title":"Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS)","volume":"159","author":"Zhang","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0045","first-page":"213","article-title":"Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells","volume":"5","author":"Graves","year":"2004","journal-title":"Amyotroph Lateral Sc."},{"key":"10.1016\/j.neulet.2016.07.039_bib0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1568007033482643","article-title":"Extracellular A. T. P. and neurodegeneration","volume":"2","author":"Volonte","year":"2003","journal-title":"Curr. Drug Targets CNS Neurol. disord."},{"key":"10.1016\/j.neulet.2016.07.039_bib0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/vim.2013.0044","article-title":"Transcript analysis of P2X receptors in PBMCs of chronic HCV patients: an insight into antiviral treatment response and HCV-Induced pathogenesis","volume":"26","author":"Ashraf","year":"2013","journal-title":"Viral Immunol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(02)01848-4","article-title":"Extracellular A.T.P. and P.2X7 receptors in neurodegeneration","volume":"447","author":"Le Feuvre","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0065","doi-asserted-by":"crossref","first-page":"23672","DOI":"10.3390\/ijms151223672","article-title":"P.2X. and P.2Y. receptors-role in the pathophysiology of the nervous system","volume":"15","author":"Puchalowicz","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2016.07.039_bib0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2006.06.008","article-title":"MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS)","volume":"179","author":"Zhang","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0075","first-page":"293","article-title":"World federation of neurology research group on motor neuron d. el escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph. Lateral. Scler."},{"key":"10.1016\/j.neulet.2016.07.039_bib0080","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2016.07.039_bib0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2009.02.012","article-title":"Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process","volume":"210","author":"Mantovani","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0090","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s12017-014-8321-y","article-title":"Mitochondrial oxidative phosphorylation transcriptome alterations in human amyotrophic lateral sclerosis spinal cord and blood","volume":"16","author":"Ladd","year":"2014","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.neulet.2016.07.039_bib0095","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/ana.20675","article-title":"Reduced expression of metabotropic glutamate receptor 2mRNA in T cells of ALS patients","volume":"58","author":"Poulopoulou","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0100","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ana.410360608","article-title":"The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic-lateral-sclerosis","volume":"36","author":"Alexianu","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0105","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.4049\/jimmunol.1203262","article-title":"The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis","volume":"190","author":"Apolloni","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0110","doi-asserted-by":"crossref","first-page":"861231","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.neulet.2016.07.039_bib0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1096\/fj.09-138883","article-title":"The P2X7 purinergic receptor: from physiology to neurological disorders","volume":"24","author":"Skaper","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.neulet.2016.07.039_bib0120","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1093\/hmg\/ddt259","article-title":"Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Apolloni","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2016.07.039_bib0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneuroim.2013.03.006","article-title":"Peroxiredoxin I. is a ROS\/p38 MAPK-dependent inducible antioxidant that regulates NF-kappaB-mediated iNOS induction and microglial activation","volume":"259","author":"Kim","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/sj.ejhg.5201961","article-title":"ALS predisposition modifiers: knock NOX, who's there? SOD1 mice still are","volume":"16","author":"Valdmanis","year":"2008","journal-title":"Eur. J. Hum. Genet.: EJHG"},{"key":"10.1016\/j.neulet.2016.07.039_bib0135","first-page":"1101","article-title":"Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Apolloni","year":"2014","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.neulet.2016.07.039_bib0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1054\/ceca.2001.0232","article-title":"P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ","volume":"30","author":"James","year":"2001","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neulet.2016.07.039_bib0145","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1007\/s11302-011-9278-z","article-title":"Using antibodies against P2Y and P2X receptors in purinergic signaling research","volume":"8","author":"Brass","year":"2012","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neulet.2016.07.039_bib0150","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.pharmtox.40.1.563","article-title":"Pharmacology of cloned P2X receptors","volume":"40","author":"North","year":"2000","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0155","doi-asserted-by":"crossref","first-page":"e00123","DOI":"10.1002\/prp2.123","article-title":"ATP-induced cellular stress and mitochondrial toxicity in cells expressing purinergic P2X7 receptor","volume":"3","author":"Seeland","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.neulet.2016.07.039_bib0160","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1038\/cddis.2012.144","article-title":"ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation","volume":"3","author":"Riteau","year":"2012","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.neulet.2016.07.039_bib0165","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","article-title":"The P2X7 receptor: a key player in IL-1 processing and release","volume":"176","author":"Ferrari","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2016.07.039_bib0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-11-94","article-title":"Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis","volume":"11","author":"Italiani","year":"2014","journal-title":"J. Neuroinflammation"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030439401630533X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030439401630533X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:19:13Z","timestamp":1759609153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030439401630533X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"alternative-id":["S030439401630533X"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.07.039","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down-regulation of purinergic P2X7 receptor expression and intracellular calcium dysregulation in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}